|
Proximal*
| | | | | |
|
Hyperplastic polyp (HP)
|
5
|
5 (100%)
|
0
|
0
|
0
|
|
Sessile serrated polyp/adenoma (SSA)
|
2
|
2 (100%)
|
0
|
0
|
0
|
|
Mixed polyp with SSA and adenoma (MP)
|
1
|
1 (100%)
|
0
|
0
|
0
|
|
Traditional serrated adenoma
|
8
|
4 (50%)
|
3 (38%)
|
1 (13%)
|
4 (50%)
|
|
Tubular adenoma (TA)
|
120
|
53 (44%)
|
47 (39%)
|
20 (17%)
|
67 (56%)
|
|
Tubulovillous adenoma (TVA)
|
32
|
11 (34%)
|
9 (28%)
|
12 (38%)
|
21 (66%)
|
|
Villous adenoma (VA)
|
3
|
1 (33%)
|
1 (33%)
|
1 (33%)
|
2 (67%)
|
|
Adenoma with intramucosal carcinoma
|
7
|
3 (43%)
|
1 (14%)
|
3 (43%)
|
4 (57%)
|
|
Adenocarcinoma with serration
|
34
|
6 (18%)
|
7 (21%)
|
21 (62%)
|
28 (82%)
|
|
Adenocarcinoma without serration
|
31
|
8 (26%)
|
7 (23%)
|
16 (52%)
|
23 (74%)
|
|
Distal*
| | | | | |
|
Hyperplastic polyp (HP)
|
17
|
14 (82%)
|
2 (12%)
|
1 (5.9%)
|
3 (28%)
|
|
Sessile serrated polyp/adenoma (SSA)
|
4
|
2 (50%)
|
2 (50%)
|
0
|
2 (50%)
|
|
Mixed polyp with SSA and adenoma (MP)
|
3
|
2 (67%)
|
1 (33%)
|
0
|
1 (33%)
|
|
Traditional serrated adenoma
|
19
|
4 (21%)
|
11 (58%)
|
4 (21%)
|
15 (79%)
|
|
Tubular adenoma (TA)
|
192
|
76 (40%)
|
57 (30%)
|
59 (31%)
|
116 (60%)
|
|
Tubulovillous adenoma (TVA)
|
65
|
35 (54%)
|
16 (25%)
|
14 (22%)
|
30 (46%)
|
|
Villous adenoma (VA)
|
9
|
4 (44%)
|
3 (33%)
|
2 (22%)
|
5 (56%)
|
|
Adenoma with intramucosal carcinoma
|
12
|
2 (17%)
|
5 (42%)
|
5 (42%)
|
10 (83%)
|
|
Adenocarcinoma with serration
|
34
|
3 (8.8%)
|
4 (12%)
|
27 (79%)
|
31 (91%)
|
|
Adenocarcinoma without serration
|
42
|
4 (9.5%)
|
9 (21%)
|
29 (69%)
|
38 (90%)
|
